Integrating Multiplexed Imaging and Multiscale Modeling Identifies Tumor Phenotype Transformation as a Critical Component of Therapeutic T Cell Efficacy.
Publication
, Preprint
Hickey, JW; Agmon, E; Horowitz, N; Lamore, M; Sunwoo, J; Covert, M; Nolan, GP
December 8, 2023
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Citation
APA
Chicago
ICMJE
MLA
NLM
Hickey, J. W., Agmon, E., Horowitz, N., Lamore, M., Sunwoo, J., Covert, M., & Nolan, G. P. (2023). Integrating Multiplexed Imaging and Multiscale Modeling Identifies Tumor Phenotype Transformation as a Critical Component of Therapeutic T Cell Efficacy. https://doi.org/10.1101/2023.12.06.570168
Hickey, John W., Eran Agmon, Nina Horowitz, Matthew Lamore, John Sunwoo, Markus Covert, and Garry P. Nolan. “Integrating Multiplexed Imaging and Multiscale Modeling Identifies Tumor Phenotype Transformation as a Critical Component of Therapeutic T Cell Efficacy.,” December 8, 2023. https://doi.org/10.1101/2023.12.06.570168.
Hickey JW, Agmon E, Horowitz N, Lamore M, Sunwoo J, Covert M, et al. Integrating Multiplexed Imaging and Multiscale Modeling Identifies Tumor Phenotype Transformation as a Critical Component of Therapeutic T Cell Efficacy. 2023.
Hickey, John W., et al. Integrating Multiplexed Imaging and Multiscale Modeling Identifies Tumor Phenotype Transformation as a Critical Component of Therapeutic T Cell Efficacy. 8 Dec. 2023. Pubmed, doi:10.1101/2023.12.06.570168.
Hickey JW, Agmon E, Horowitz N, Lamore M, Sunwoo J, Covert M, Nolan GP. Integrating Multiplexed Imaging and Multiscale Modeling Identifies Tumor Phenotype Transformation as a Critical Component of Therapeutic T Cell Efficacy. 2023.